参考文献/References:
[1] Fajans SS, Bell GI. MODY: history, genetics, pathophysiology, and clinical decision making[J].Diabetes Care,2011,34(8):1878-1884. DOI:10.2337/dc11-0035.
[2] Schwitzgebel VM. Many faces of monogenic diabetes[J].J Diabetes Investig,2014,5(2):121-133. DOI:10.1111/jdi.12197.
[3] Sachdeva MM, Claiborn KC, Khoo C,et al. Pdx1(MODY4)regulates pancreatic beta cell susceptibility to ER stress[J].Proc Natl Acad Sci U S A,2009,106(45):19090-19095. DOI:10.1073/pnas.0904849106.
[4] Rubio-Cabezas O, Jensen JN, Hodgson MI,et al.Permanent neonatal diabetes and enteric anendocrinosis associated with biallelic mutations in NEUROG3[J].Diabetes,2011,60(4):1349-1353. DOI:10.2337/db10-1008.
[5] McDonald TJ, Ellard S. Maturity onset diabetes of the young: identification and diagnosis[J].Ann Clin Biochem,2013,50(Pt 5):403-415. DOI:10.1177/0004563213483458.
[6] Owen KR, Thanabalasingham G, James TJ,et al. Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations[J].Diabetes Care,2010,33(9):1919-1924. DOI:10.2337/dc10-0288.
[7] McDonald TJ, Shields BM, Lawry J,et al. High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes[J].Diabetes Care,2011,34(8):1860-1862. DOI:10.2337/dc11-0323.
[8] Bonnycastle LL, Chines PS, Hara T,et al. Autosomal dominant diabetes arising from a Wolfram syndrome 1 mutation[J].Diabetes,2013,62(11):3943-3950. DOI:10.2337/db13-0571.
[9] Mozzillo E, Delvecchio M, Carella M,et al. A novel CISD2 intragenic deletion, optic neuropathy and platelet aggregation defectin Wolfram syndrome type 2[J].BMC Med Genet,2014,15:88. DOI:10.1186/1471-2350-15-88.
[10] Sun J, Cui J, He Q,et al. Proinsulin misfolding and endoplasmic reticulum stress during the development and progression of diabetes[J].Mol Aspects Med,2015,42:105-118. DOI:10.1016/j.mam.2015.01.001.
[11] Garin I, Edghill EL, Akerman I,et al. Recessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesis[J].Proc Natl Acad Sci U S A,2010,107(7):3105-3110. DOI:10.1073/pnas.0910533107.
[12] van de Bunt M, Gloyn AL. A tale of two glucose transporters: how GLUT2 re-emerged as a contender for glucosetransport into the human beta cell [J].Diabetologia,2012,55(9):2312-2315. DOI:10.1007/s00125-012-2612-3.
[13] Njølstad PR, Søvik O, Cuesta-Muñoz A,et al. Neonatal diabetes mellitus due to complete glucokinase deficiency[J].N Engl J Med,2001,344(21):1588-1592.DOI:10.1056/NEJM200105243442104.
[14] Flack JR, Ross GP, Cheung NW. GCK monogenic diabetes and gestational diabetes: possible diagnosis on clinical grounds[J].Diabet Med,2015,32(12):1596-1601. DOI:10.1111/dme.12830.
[15] Bacchetta R, Barzaghi F, Roncarolo MG. From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation[J].Ann N Y Acad Sci,2016. DOI:10.1111/nyas.13011.
[16] 巩纯秀,曹冰燕. 新生儿糖尿病分子遗传学机制研究进展[J]. 中华实用儿科临床杂志,2015(20):1521-1524. DOI:10.3760/cma.j.issn.2095-428X.2015.20.001.
[17] Tahir S, Leijssen LG, Sherif M,et al. A novel homozygous SLC19A2 mutation in a Portuguese patient with diabetes mellitus and thiamine-responsive megaloblastic anaemia[J].Int J Pediatr Endocrinol,2015,2015(1):6. DOI:10.1186/s13633-015-0002-6.
[18] 张辛寒,翁建平. 6q24暂时性新生儿糖尿病的病因及临床特点[J]. 中华糖尿病杂志,2015(6):387-389. DOI:10.3760/cma.j.issn.1674-5809.2015.06.011.
[19] Melki I, Lambot K, Jonard L,et al. Mutation in the SLC29A3 gene: a new cause of a monogenic, autoinflammatory condition[J].Pediatrics,2013,131(4):e1308-e1313. DOI:10.1542/peds.2012-2255.
[20] Rubio-Cabezas O, Hattersley AT, Njølstad PR,et al. ISPAD Clinical Practice Consensus Guidelines 2014. The diagnosis and management of monogenic diabetes in children and adolescents[J].Pediatr Diabetes,2014,15(Suppl 20):47-64.DOI:10.1111/pedi.12192.
[21] Owen KR. Monogenic diabetes: the treatment options[J].Diabet Med,2015,32(4):429-430. DOI:10.1111/dme.12721.
[22] Lachance CH. Practical aspects of monogenic diabetes: a clinical point of view[J].Can J Diabetes,2016,40(5):368-375. DOI:10.1016/j.jcjd.2015.11.004.
[23] Balamurugan K, Bjørkhaug L, Mahajan S,et al.Structure-function studies of HNF1A(MODY3)gene mutations in South Indian patients with monogenic diabetes[J].Clin Genet,2016,90(6):486-495. DOI:10.1111/cge.12757.
相似文献/References:
[1]周庆菊,李蓉.MODY2的认识及诊疗进展[J].国际内分泌代谢杂志,2016,36(03):180.[doi:10.3760/cma.j.issn.1673-4157.2016.03.09]
Zhou Qingju,Li Rong..The cognition, diagnosis and treatment of MODY2[J].International Journal of Endocrinology and Metabolism,2016,36(04):180.[doi:10.3760/cma.j.issn.1673-4157.2016.03.09]
[2]曲玉清,王安平,王先令,等.单基因突变致激素不敏感综合征的研究进展[J].国际内分泌代谢杂志,2017,37(01):59.[doi:10.3760/cma.j.issn.1673-4157.2017.01.17]
Qu Yuqing,Wang Anping,Wang Xianling,et al.Research progress in hormone insensitivity syndrome caused by single gene mutation[J].International Journal of Endocrinology and Metabolism,2017,37(04):59.[doi:10.3760/cma.j.issn.1673-4157.2017.01.17]
[3]郭曼丽,李伟,马绍刚,等.甲状腺过氧化物酶基因c.2268dupT突变与甲状腺结节的相关性研究[J].国际内分泌代谢杂志,2017,37(04):232.
Guo Manli*,Li Wei,Ma Shaogang,et al.Relationship between c.2268dupT mutation in thyroid peroxidase gene and thyroid nodules[J].International Journal of Endocrinology and Metabolism,2017,37(04):232.
[4]王慧萍,童安莉.原发性醛固酮增多症相关的基因突变研究进展[J].国际内分泌代谢杂志,2021,41(02):87.[doi:10.3760/cma.j.cn121383-20200706-07013]
Wang Huiping,Tong Anli..Research progress on gene mutation related primary aldosteronism[J].International Journal of Endocrinology and Metabolism,2021,41(04):87.[doi:10.3760/cma.j.cn121383-20200706-07013]
[5]彭雅洁,朱文娇,施缘萍,等.DNA损伤修复和遗传缺陷导致的脂肪分化异常及胰岛素抵抗的研究进展[J].国际内分泌代谢杂志,2022,42(03):219.[doi:10.3760/cma.j.cn121383-20210120-01056]
Peng Yajie,Zhu Wenjiao,Shi Yuanping,et al.Abnormal adipose differentiation and insulin resistance caused by DNA damage repair and genetic defects[J].International Journal of Endocrinology and Metabolism,2022,42(04):219.[doi:10.3760/cma.j.cn121383-20210120-01056]
[6]秦晓燕,师萍,管庆波,等.青少年发病的成年型糖尿病分子遗传学研究进展[J].国际内分泌代谢杂志,2022,42(05):382.[doi:10.3760/cma.j.cn121383-20210412-04032]
Qin Xiaoyan,Shi Ping,Guan Qingbo,et al.Advances in molecular genetics of maturity-onset diabetes of the young[J].International Journal of Endocrinology and Metabolism,2022,42(04):382.[doi:10.3760/cma.j.cn121383-20210412-04032]
[7]谢梦晨,郭洋洋,黄金慧,等.原发性醛固酮增多症基因型与临床表型关系的研究进展[J].国际内分泌代谢杂志,2023,43(03):216.[doi:10.3760/cma.j.cn121383-20220307-03015]
Xie Mengchen,Guo Yangyang,Huang Jinhui,et al.Association of genotype and clinical phenotype of primary aldosteronism[J].International Journal of Endocrinology and Metabolism,2023,43(04):216.[doi:10.3760/cma.j.cn121383-20220307-03015]
[8]刘海春 高洪波 李赟 李隆敏 邵玉军.基因突变对嗜铬细胞瘤/副神经节瘤临床特征及预后的影响[J].国际内分泌代谢杂志,2023,43(05):392.[doi:10.3760/cma.j.cn121383-20221029-10044]
Liu Haichun,Gao Hongbo,Li Yun,et al.Effect of gene mutations on clinical features and prognosis of pheochromocytoma/paraganglioma[J].International Journal of Endocrinology and Metabolism,2023,43(04):392.[doi:10.3760/cma.j.cn121383-20221029-10044]
[9]中华医学会内分泌学分会内分泌罕见病学组.葡萄糖激酶基因突变导致的单基因糖尿病诊治专家共识[J].国际内分泌代谢杂志,2022,42(03):236.[doi:10.3760/cma.j.cn121383-20220107-01010]
Study Group of Endocrinology Rare Diseases,Chinese Society of Endocrinology.Diagnosis and management of monogenic diabetes caused by glucokinase gene mutations[J].International Journal of Endocrinology and Metabolism,2022,42(04):236.[doi:10.3760/cma.j.cn121383-20220107-01010]